Congressional Briefings

In Annual Hill Briefing, Law Enforcement Authorities and Current and Former DEA Agents Share Details on Danger Posed by Counterfeit Drugs and Illicit Fentanyl Imports

Photo of Javier Peña, Steve Murphy and Aaron Graham

In Capitol Hill briefings sponsored by the Partnership for Safe Medicines (PSM) on January 31, former and current law enforcement leaders sounded a warning over the increased flow of counterfeit drugs and lethal fentanyl into the United States, noting that international drug traffickers and crime syndicates see our nation as a lucrative market.


PSM Went to Congress to Share Our Concerns About The Threat of Counterfeit Medicine

On Thursday, January 31, 2018, the Partnership for Safe Medicines held two briefings in Washington, D.C. to inform members of Congress and their staff about the dangers posed to Americans by counterfeit medicines. The events each had three panels and looked at how fake medicines have affected individuals and law enforcement, and also at the roles played by international bad actors and drug cartels…


Partnership For Safe Medicines 2019 Congressional Briefings

On Thursday, January 31, 2019, victims of counterfeit medicines and their families, local law enforcement, former DEA agents, and other experts in the fight against counterfeit medicines met for a discussion about the widespread impact fake drugs are having on communities and on the enormous burden the problem places on regulators who are responsible for our drug safety.

Learn more and watch the briefing here.


Want to meet the original DEA agents from Netflix’s NARCOS?

This event is going to be popular – register to secure your seat. Priority will be given to registered congressional staff. Former DEA Agents Who Inspired Netflix Series “Narcos” Join Policymakers to Discuss Latest Threats Posed By Illegally-Imported Fentanyl House Energy and Commerce Committee Chair Rep. Greg Walden (R-Oregon), Members of Congress, Law Enforcement Experts, Industry Leaders…


“Current Threats to American Patients from Counterfeiters,” March 7-8, 2016

“Current Threats to American Patients from Counterfeiters,” March 7-8, 2016 In a case currently in US courts, the Department of Justice alleges that sold $78 million worth of unapproved, mislabeled and counterfeit cancer drugs to doctors throughout the US between 2009 and 2012.  The case, which is one of several cases in recent years involving the sale of counterfeit…


The Partnership for Safe Medicines Congressional Briefing March 16 -17, 2017

In 2017, the danger of counterfeit drugs is serious and ubiquitous in America, touching all 50 states. Large-scale smugglers bring in fake cancer drugs containing nothing but mold and water and sell them at a discount to oncologists. Fake pills containing deadly doses of fentanyl appear in the supply chain either from fake online pharmacies…


Congressional Briefing: The Human Impact of Counterfeit Drugs

Congressional Briefing: The Human Impact of Counterfeit Drugs As the recent seizure of more than 8,000 counterfeit pills labeled as “harmless generic medicine” at the Cincinnati/Northern Kentucky International Airport demonstrates, Americans are not immune from the dangers of counterfeit drugs.  This is a global public health threat that is gaining increasing national attention from the media (60…